Regenxbio Stock Story
RGNX Stock | USD 16.04 0.14 0.88% |
Slightly above 64% of all Regenxbio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Regenxbio suggests that some traders are interested. Regenxbio's investor sentiment overview provides quick insight into current market opportunities from investing in Regenxbio. The current market sentiment, together with Regenxbio's historical and current headlines, can help investors time the market. In addition, many technical investors use Regenxbio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Regenxbio stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Regenxbio daily returns and investor perception about the current price of Regenxbio as well as its diversification or hedging effects on your existing portfolios.
Regenxbio |
Requested story not found. it has been either deleted or moved. View all stories for Regenxbio.
Regenxbio Latest Timeline
Regenxbio is listed for 16.04. The company reported the previous year's revenue of 90.24 M. Net Loss for the year was (263.49 M) with loss before overhead, payroll, taxes, and interest of (184.27 M).Check out Regenxbio Hype Analysis, Regenxbio Correlation and Regenxbio Performance. For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Regenxbio Stock analysis
When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world |
Is Regenxbio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regenxbio. If investors know Regenxbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regenxbio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.02) | Revenue Per Share 2.063 | Quarterly Revenue Growth (0.29) | Return On Assets (0.23) | Return On Equity (0.64) |
The market value of Regenxbio is measured differently than its book value, which is the value of Regenxbio that is recorded on the company's balance sheet. Investors also form their own opinion of Regenxbio's value that differs from its market value or its book value, called intrinsic value, which is Regenxbio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regenxbio's market value can be influenced by many factors that don't directly affect Regenxbio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regenxbio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regenxbio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regenxbio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.